ALPROSTADIL

ALPROSTADIL was reported 3625 times

ALPROSTADIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFANTILE CORTICAL HYPEROSTOSIS 11 0.5000
1 HARLEQUIN SKIN REACTION 5 0.3333
2 PENIS DEVIATION 4 0.1111
3 CARTILAGE HYPERTROPHY 2 0.1000
4 NEONATAL APNOEIC ATTACK 6 0.0741
5 CAPILLARY FRAGILITY INCREASED 2 0.0690
6 PAINFUL ERECTION 47 0.0681
7 PENILE CURVATURE 16 0.0681
8 INFANTILE APNOEIC ATTACK 14 0.0598
9 ARTERIOSCLEROSIS OBLITERANS 4 0.0494
10 FEVER NEONATAL 6 0.0458
11 PEYRONIE'S DISEASE 8 0.0442
12 PENILE BURNING SENSATION 12 0.0423
13 BASE EXCESS NEGATIVE 2 0.0377
14 SCLEREMA 3 0.0370
15 INCISION SITE PAIN 43 0.0366
16 RED BLOOD CELLS URINE POSITIVE 33 0.0341
17 NEONATAL HYPONATRAEMIA 4 0.0328
18 ARM AMPUTATION 6 0.0328
19 ERECTION INCREASED 136 0.0325
20 PENILE DISCOMFORT 4 0.0310
21 MUCOCUTANEOUS ULCERATION 7 0.0308
22 ENDOTOXIC SHOCK 2 0.0290
23 CARDIAC SEPTAL HYPERTROPHY 8 0.0289
24 PENILE PAIN 88 0.0289
25 THROMBOANGIITIS OBLITERANS 3 0.0288
26 PENIS INJURY 10 0.0278
27 PENILE NECROSIS 3 0.0270
28 APNOEIC ATTACK 14 0.0248
29 COMPUTERISED TOMOGRAM HEART ABNORMAL 2 0.0244
30 BASILAR ARTERY OCCLUSION 4 0.0241
31 PRIAPISM 81 0.0235
32 PENILE HAEMORRHAGE 19 0.0233
33 VESSEL PUNCTURE SITE HAEMATOMA 4 0.0203
34 INFANTILE APNOEA 16 0.0196
35 BALANITIS 2 0.0164
36 SYSTOLIC HYPERTENSION 7 0.0162
37 PENIS DISORDER 38 0.0153
38 CARDIAC ARREST NEONATAL 2 0.0145
39 SHUNT STENOSIS 4 0.0144
40 PENILE SWELLING 17 0.0139
41 URETHRAL HAEMORRHAGE 8 0.0132
42 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5 0.0129
43 PENILE SIZE REDUCED 12 0.0126
44 BONE HYPERTROPHY 2 0.0124
45 PROSTATECTOMY 7 0.0122
46 PERIOSTITIS 5 0.0116
47 DELAYED GRAFT FUNCTION 8 0.0113
48 PULMONARY HYPERTENSIVE CRISIS 3 0.0111
49 ANTITHROMBIN III DECREASED 3 0.0110
50 PENILE CONTUSION 5 0.0104
51 PROSTATIC OPERATION 12 0.0100
52 NEONATAL HYPOXIA 8 0.0097
53 HEPATECTOMY 3 0.0096
54 PENILE ULCERATION 3 0.0092
55 WRONG STRENGTH 3 0.0091
56 CONGENITAL PULMONARY VALVE ATRESIA 2 0.0090
57 ENDOTHELIAL DYSFUNCTION 2 0.0087
58 TONGUE INJURY 8 0.0085
59 URETHRAL PAIN 5 0.0085
60 FAT EMBOLISM 3 0.0085
61 VASCULITIS NECROTISING 6 0.0084
62 NEONATAL HYPOTENSION 3 0.0082
63 GASTRIC MUCOSAL HYPERTROPHY 2 0.0081
64 PENILE ERYTHEMA 3 0.0080
65 CYSTITIS VIRAL 3 0.0078
66 CONVULSION NEONATAL 4 0.0076
67 INCISION SITE IMPAIRED HEALING 3 0.0074
68 CYTOMEGALOVIRUS VIRAEMIA 33 0.0074
69 ILIAC ARTERY OCCLUSION 2 0.0073
70 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0071
71 COMPLICATIONS OF TRANSPLANTED KIDNEY 16 0.0070
72 GENITAL PARAESTHESIA 2 0.0069
73 CYANOPSIA 4 0.0067
74 CAPILLARY LEAK SYNDROME 13 0.0063
75 PO2 DECREASED 7 0.0061
76 PROTEIN URINE PRESENT 30 0.0060
77 EXPOSURE VIA PARTNER 3 0.0060
78 BILIRUBIN CONJUGATED INCREASED 13 0.0056
79 SCROTAL PAIN 3 0.0056
80 TRANSIENT GLOBAL AMNESIA 4 0.0055
81 NEUTROPHIL COUNT INCREASED 54 0.0053
82 CYSTITIS HAEMORRHAGIC 21 0.0052
83 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0051
84 URETERIC STENOSIS 4 0.0050
85 GRANULOCYTE COUNT INCREASED 2 0.0049
86 DUCTUS ARTERIOSUS PREMATURE CLOSURE 2 0.0049
87 AMPUTATION 6 0.0048
88 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
89 GENITAL BURNING SENSATION 4 0.0046
90 CARDIAC OUTPUT DECREASED 4 0.0045
91 LYMPHOCYTE COUNT DECREASED 79 0.0045
92 FEEDING INTOLERANCE 2 0.0044
93 TESTICULAR PAIN 14 0.0044
94 URETHRAL STENOSIS 3 0.0044
95 HYPOPROTEINAEMIA 8 0.0042
96 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
97 PHIMOSIS 3 0.0041
98 PULMONARY HYPOPLASIA 3 0.0038
99 FRACTURE OF PENIS 2 0.0038
100 NEONATAL DISORDER 6 0.0038
101 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
102 HYPERAMYLASAEMIA 2 0.0037
103 ERECTILE DYSFUNCTION 93 0.0036
104 BLOOD PH INCREASED 2 0.0036
105 PULMONARY SARCOIDOSIS 4 0.0036
106 KIDNEY TRANSPLANT REJECTION 17 0.0035
107 BLOOD UREA INCREASED 59 0.0035
108 BLOOD OESTROGEN INCREASED 2 0.0034
109 BLOOD ALBUMIN INCREASED 3 0.0034
110 MUSCLE SWELLING 3 0.0033
111 BLOOD BILIRUBIN DECREASED 2 0.0032
112 OBSTRUCTION GASTRIC 4 0.0031
113 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
114 HIGH DENSITY LIPOPROTEIN INCREASED 3 0.0030
115 HIGH DENSITY LIPOPROTEIN DECREASED 10 0.0030
116 TESTICULAR DISORDER 3 0.0030
117 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
118 GASTROINTESTINAL INFECTION 26 0.0029
119 NECROSIS 16 0.0029
120 SYSTOLIC DYSFUNCTION 3 0.0028
121 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
122 CEREBRAL VASOCONSTRICTION 2 0.0027
123 EPSTEIN-BARR VIRAEMIA 3 0.0027
124 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
125 KLEBSIELLA SEPSIS 3 0.0027
126 BLOOD ALBUMIN DECREASED 21 0.0026
127 ACUTE GRAFT VERSUS HOST DISEASE 12 0.0026
128 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
129 PATENT DUCTUS ARTERIOSUS 10 0.0025
130 EJACULATION FAILURE 5 0.0025
131 BARRETT'S OESOPHAGUS 2 0.0025
132 INCISION SITE HAEMORRHAGE 2 0.0025
133 APNOEA 19 0.0024
134 ACCIDENTAL NEEDLE STICK 2 0.0024
135 TESTICULAR SWELLING 3 0.0024
136 NECROTISING COLITIS 3 0.0024
137 CAROTID ARTERY THROMBOSIS 2 0.0024
138 POSTOPERATIVE WOUND COMPLICATION 3 0.0024
139 CRANIOFACIAL FRACTURE 2 0.0023
140 APGAR SCORE LOW 3 0.0023
141 LIBIDO DISORDER 3 0.0023
142 ARTERIAL STENOSIS 2 0.0023
143 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
144 EXPIRED DRUG ADMINISTERED 11 0.0022
145 URETERIC OBSTRUCTION 3 0.0022
146 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
147 HAEMATOTOXICITY 20 0.0021
148 GENITAL RASH 3 0.0021
149 VASCULAR INJURY 3 0.0021
150 BLOOD URINE 2 0.0021
151 ANAL CANCER 2 0.0021
152 HEPATIC FIBROSIS 7 0.0020
153 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
154 PERIPHERAL ISCHAEMIA 8 0.0020
155 FACIAL BONES FRACTURE 7 0.0019
156 CAROTID ARTERIOSCLEROSIS 2 0.0019
157 ENTEROCOLITIS 11 0.0019
158 DEVICE INEFFECTIVE 2 0.0019
159 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
160 PARESIS 4 0.0018
161 ENTEROBACTER INFECTION 3 0.0018
162 BK VIRUS INFECTION 6 0.0018
163 DEVICE FAILURE 27 0.0018
164 NEUROPATHY 3 0.0018
165 BLOODY DISCHARGE 2 0.0017
166 WOUND COMPLICATION 6 0.0017
167 INCORRECT STORAGE OF DRUG 3 0.0017
168 NEPHROGENIC ANAEMIA 8 0.0017
169 EPIDIDYMITIS 2 0.0017
170 PSEUDOMONAL SEPSIS 3 0.0017
171 HYPERURICAEMIA 7 0.0017
172 LEG AMPUTATION 7 0.0017
173 NEEDLE ISSUE 49 0.0017
174 CHRONIC GRAFT VERSUS HOST DISEASE 6 0.0017
175 CEREBRAL ARTERY EMBOLISM 2 0.0016
176 VIRAL MUTATION IDENTIFIED 6 0.0016
177 PUPILLARY REFLEX IMPAIRED 3 0.0016
178 BLOOD CHOLESTEROL DECREASED 3 0.0016
179 ANGIOPATHY 9 0.0016
180 HYPERPARATHYROIDISM SECONDARY 4 0.0016
181 BLOOD CREATININE DECREASED 5 0.0016
182 VENTRICULAR HYPERTROPHY 4 0.0016
183 BRADYCARDIA NEONATAL 2 0.0016
184 PRODUCT SOLUBILITY ABNORMAL 8 0.0016
185 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
186 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
187 TRAUMATIC LUNG INJURY 3 0.0016
188 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
189 PORTAL VEIN THROMBOSIS 5 0.0015
190 SKIN NECROSIS 8 0.0015
191 ASPERGILLOSIS 2 0.0015
192 ISCHAEMIA 7 0.0015
193 EXFOLIATIVE RASH 4 0.0015
194 ARTERIOSPASM CORONARY 6 0.0015
195 GANGRENE 9 0.0015
196 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
197 ARTERIOSCLEROSIS 14 0.0015
198 ANORGASMIA 4 0.0015
199 GENERALISED OEDEMA 18 0.0015
200 DILATATION VENTRICULAR 3 0.0014
201 ACUTE PULMONARY OEDEMA 8 0.0014
202 DEVICE CONNECTION ISSUE 3 0.0014
203 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
204 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
205 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
206 HEPATIC NEOPLASM MALIGNANT 3 0.0014
207 LUNG INFECTION 22 0.0014
208 HYPOALBUMINAEMIA 11 0.0014
209 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0014
210 POOR QUALITY DRUG ADMINISTERED 9 0.0014
211 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
212 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
213 WHITE BLOOD CELL COUNT INCREASED 52 0.0014
214 DRUG EFFECT DECREASED 73 0.0014
215 GENITAL PAIN 2 0.0014
216 PROSTATITIS 4 0.0013
217 SYRINGE ISSUE 23 0.0013
218 CAESAREAN SECTION 15 0.0013
219 PROSTATIC DISORDER 7 0.0013
220 DRUG EFFECT INCREASED 4 0.0013
221 INJECTION SITE INJURY 7 0.0013
222 HYPERLIPIDAEMIA 15 0.0013
223 FOREIGN BODY 5 0.0012
224 MACULAR OEDEMA 7 0.0012
225 AORTIC VALVE DISEASE 2 0.0012
226 PANNICULITIS 3 0.0012
227 ACUTE LEUKAEMIA 2 0.0012
228 COLONIC POLYP 2 0.0012
229 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
230 VENOOCCLUSIVE DISEASE 3 0.0012
231 BLADDER CANCER STAGE IV 2 0.0012
232 SEXUAL DYSFUNCTION 14 0.0012
233 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
234 HEPATORENAL SYNDROME 2 0.0012
235 TOE AMPUTATION 6 0.0012
236 PROTHROMBIN TIME PROLONGED 7 0.0012
237 BLOOD TESTOSTERONE DECREASED 8 0.0012
238 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
239 BLOOD CHLORIDE INCREASED 2 0.0012
240 VENTRICULAR DYSFUNCTION 3 0.0012
241 MUCORMYCOSIS 3 0.0012
242 EXTREMITY NECROSIS 2 0.0011
243 MYOCARDIAL ISCHAEMIA 13 0.0011
244 BLOOD CREATINE INCREASED 5 0.0011
245 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
246 FOREIGN BODY IN REPRODUCTIVE TRACT 10 0.0011
247 PROCEDURAL PAIN 31 0.0011
248 BLOOD SODIUM INCREASED 3 0.0011
249 INJURY ASSOCIATED WITH DEVICE 22 0.0011
250 HAEMODIALYSIS 9 0.0011
251 PARAPLEGIA 3 0.0010
252 ARTERIAL THROMBOSIS 2 0.0010
253 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
254 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
255 PROSTATOMEGALY 4 0.0010
256 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
257 STAPHYLOCOCCAL SEPSIS 5 0.0010
258 URINE ANALYSIS ABNORMAL 3 0.0010
259 ASPHYXIA 8 0.0010
260 FIBROSIS 3 0.0010
261 GRAFT VERSUS HOST DISEASE 7 0.0010
262 PERIPHERAL VASCULAR DISORDER 5 0.0010
263 HYPERPARATHYROIDISM 2 0.0010
264 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
265 C-REACTIVE PROTEIN INCREASED 35 0.0010
266 BLOOD BLISTER 3 0.0010
267 AORTIC VALVE INCOMPETENCE 4 0.0009
268 THROMBOTIC MICROANGIOPATHY 9 0.0009
269 CARDIAC FAILURE 74 0.0009
270 HENOCH-SCHONLEIN PURPURA 2 0.0009
271 DEAFNESS NEUROSENSORY 3 0.0009
272 PULMONARY HAEMORRHAGE 7 0.0009
273 CEREBRAL HAEMATOMA 3 0.0009
274 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
275 NEOPLASM RECURRENCE 3 0.0009
276 PRODUCT LABEL ISSUE 6 0.0009
277 DRUG EFFECT DELAYED 4 0.0009
278 ECCHYMOSIS 6 0.0009
279 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
280 THROMBOPHLEBITIS 3 0.0009
281 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
282 HAEMORRHAGIC DIATHESIS 3 0.0008
283 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
284 DIABETES INSIPIDUS 2 0.0008
285 STILLBIRTH 4 0.0008
286 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30 0.0008
287 DIZZINESS POSTURAL 8 0.0008
288 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
289 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5 0.0008
290 HAEMOGLOBIN DECREASED 83 0.0008
291 VEIN DISORDER 4 0.0008
292 DRUG EFFECT INCOMPLETE 29 0.0008
293 GROIN PAIN 7 0.0008
294 PROTEIN TOTAL DECREASED 3 0.0008
295 RESPIRATORY RATE INCREASED 7 0.0008
296 MOTOR DYSFUNCTION 8 0.0008
297 ISCHAEMIC STROKE 14 0.0008
298 DEVICE MALFUNCTION 55 0.0008
299 DISSEMINATED TUBERCULOSIS 2 0.0008
300 PROCTALGIA 5 0.0008
301 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
302 ATRIOVENTRICULAR BLOCK 6 0.0008
303 DRUG TITRATION ERROR 2 0.0008
304 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
305 ACTINIC KERATOSIS 2 0.0008
306 HEPATITIS TOXIC 2 0.0008
307 COMPARTMENT SYNDROME 2 0.0008
308 VENOUS THROMBOSIS 3 0.0008
309 PRODUCT PREPARATION ISSUE 5 0.0008
310 PNEUMONIA FUNGAL 3 0.0008
311 PULMONARY CONGESTION 10 0.0008
312 PRODUCT PRESCRIBING ERROR 18 0.0008
313 HEPATIC FUNCTION ABNORMAL 28 0.0007
314 ANAESTHETIC COMPLICATION 2 0.0007
315 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
316 HYPOKALAEMIA 34 0.0007
317 BLOOD PHOSPHORUS INCREASED 2 0.0007
318 DEVICE MECHANICAL ISSUE 10 0.0007
319 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
320 COAGULOPATHY 12 0.0007
321 POOR PERIPHERAL CIRCULATION 3 0.0007
322 CARDIAC FAILURE CHRONIC 3 0.0007
323 HAEMATOLOGICAL MALIGNANCY 2 0.0007
324 DUODENAL ULCER HAEMORRHAGE 2 0.0007
325 SHOCK 16 0.0007
326 MYOPATHY 6 0.0007
327 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
328 INJECTION SITE HAEMATOMA 10 0.0007
329 URINE OUTPUT DECREASED 6 0.0007
330 PRODUCT LABEL CONFUSION 4 0.0007
331 PRODUCT QUALITY ISSUE 92 0.0007
332 POST PROCEDURAL COMPLICATION 13 0.0007
333 MEDICAL DEVICE COMPLICATION 5 0.0007
334 ATAXIA 8 0.0007
335 VENTRICULAR EXTRASYSTOLES 7 0.0007
336 HEPATITIS FULMINANT 2 0.0007
337 DRUG INEFFECTIVE 888 0.0007
338 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
339 MALIGNANT MELANOMA 9 0.0007
340 BRAIN HERNIATION 2 0.0007
341 HYDRONEPHROSIS 5 0.0007
342 INJECTION SITE DISCOMFORT 7 0.0007
343 SUSPECTED OFF LABEL USE 3 0.0007
344 CYTOMEGALOVIRUS INFECTION 11 0.0007
345 PATHOGEN RESISTANCE 6 0.0007
346 ABDOMINAL HERNIA 3 0.0007
347 HAEMODYNAMIC INSTABILITY 5 0.0007
348 PHARMACEUTICAL PRODUCT COMPLAINT 17 0.0007
349 DYSPAREUNIA 3 0.0007
350 DYSAESTHESIA 2 0.0007
351 INTRACARDIAC THROMBUS 2 0.0007
352 ECTOPIC PREGNANCY 2 0.0006
353 PREGNANCY 13 0.0006
354 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
355 BRAIN DEATH 2 0.0006
356 MULTIPLE MYELOMA 3 0.0006
357 GASTRITIS EROSIVE 3 0.0006
358 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
359 DIALYSIS 9 0.0006
360 VENTRICULAR FIBRILLATION 7 0.0006
361 RENAL CYST 5 0.0006
362 BLOOD CREATININE INCREASED 41 0.0006
363 HYPOVOLAEMIC SHOCK 3 0.0006
364 PULMONARY OEDEMA 28 0.0006
365 TRANSPLANT REJECTION 5 0.0006
366 BACTERIAL SEPSIS 2 0.0006
367 ASCITES 18 0.0006
368 INCORRECT PRODUCT STORAGE 8 0.0006
369 DRUG-INDUCED LIVER INJURY 19 0.0006
370 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
371 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
372 END STAGE RENAL DISEASE 11 0.0006
373 BLOOD CHOLESTEROL INCREASED 28 0.0006
374 CARDIAC FAILURE ACUTE 4 0.0006
375 PREMATURE BABY 18 0.0006
376 DRUG TOLERANCE 3 0.0006
377 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
378 DRUG DISPENSING ERROR 9 0.0006
379 DRUG ADMINISTRATION ERROR 18 0.0006
380 CARDIAC OPERATION 5 0.0006
381 LEFT VENTRICULAR FAILURE 2 0.0006
382 SKIN ULCER 15 0.0006
383 BLOOD URINE PRESENT 11 0.0006
384 AORTIC STENOSIS 2 0.0006
385 NO THERAPEUTIC RESPONSE 7 0.0006
386 CAROTID ARTERY STENOSIS 2 0.0006
387 CYANOSIS 9 0.0006
388 IMMUNOSUPPRESSION 5 0.0006
389 PRODUCT COMMUNICATION ISSUE 5 0.0006
390 FIBRIN D DIMER INCREASED 2 0.0006
391 FRUSTRATION 2 0.0006
392 HAEMOLYTIC ANAEMIA 5 0.0006
393 MYOSITIS 5 0.0006
394 BLOOD BILIRUBIN INCREASED 15 0.0006
395 HAEMATURIA 19 0.0006
396 BLOOD POTASSIUM INCREASED 9 0.0006
397 PRODUCT DISPENSING ERROR 12 0.0006
398 CAROTID ARTERY OCCLUSION 2 0.0005
399 INTESTINAL ISCHAEMIA 3 0.0005
400 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
401 IRON DEFICIENCY ANAEMIA 5 0.0005
402 HEPATIC CANCER STAGE IV 2 0.0005
403 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
404 CANDIDA INFECTION 9 0.0005
405 PEMPHIGOID 4 0.0005
406 PRODUCT PACKAGING ISSUE 5 0.0005
407 MULTI-ORGAN FAILURE 9 0.0005
408 DRUG PRESCRIBING ERROR 10 0.0005
409 BLOOD URIC ACID INCREASED 3 0.0005
410 DEVICE DEFECTIVE 9 0.0005
411 RALES 3 0.0005
412 DYSURIA 19 0.0005
413 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
414 DIABETES MELLITUS 39 0.0005
415 PLEURAL EFFUSION 31 0.0005
416 BODY TEMPERATURE DECREASED 5 0.0005
417 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
418 TRICUSPID VALVE INCOMPETENCE 4 0.0005
419 HAEMOPTYSIS 14 0.0005
420 POOR QUALITY DEVICE USED 5 0.0005
421 HEPATITIS B 3 0.0005
422 SENSORY LOSS 4 0.0005
423 TOXIC SKIN ERUPTION 5 0.0005
424 GALLBLADDER OPERATION 2 0.0005
425 VULVOVAGINAL BURNING SENSATION 3 0.0005
426 SUBARACHNOID HAEMORRHAGE 5 0.0005
427 BODY TEMPERATURE INCREASED 10 0.0005
428 HICCUPS 4 0.0005
429 ANAPHYLACTOID REACTION 2 0.0005
430 VENTRICULAR TACHYCARDIA 8 0.0005
431 ACUTE CORONARY SYNDROME 4 0.0005
432 EXPIRED PRODUCT ADMINISTERED 16 0.0005
433 INJECTION SITE DISCOLOURATION 6 0.0005
434 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
435 CONGESTIVE CARDIOMYOPATHY 2 0.0005
436 INTENTIONAL DRUG MISUSE 10 0.0005
437 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
438 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5 0.0005
439 HAEMORRHAGE INTRACRANIAL 7 0.0005
440 DEVICE BREAKAGE 19 0.0005
441 PRODUCT CONTAINER ISSUE 4 0.0005
442 ANURIA 4 0.0005
443 ANGINA UNSTABLE 3 0.0005
444 WOUND INFECTION 5 0.0005
445 INJECTION SITE HAEMORRHAGE 36 0.0005
446 CEREBRAL INFARCTION 11 0.0004
447 ILEUS PARALYTIC 2 0.0004
448 PROSTATE CANCER 36 0.0004
449 PRODUCT ADMINISTRATION ERROR 9 0.0004
450 LOSS OF LIBIDO 4 0.0004
451 PRODUCT USE COMPLAINT 7 0.0004
452 POSTOPERATIVE WOUND INFECTION 3 0.0004
453 WRONG PRODUCT ADMINISTERED 3 0.0004
454 ABSCESS 7 0.0004
455 HAEMOGLOBIN INCREASED 2 0.0004
456 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
457 HAIR GROWTH ABNORMAL 3 0.0004
458 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
459 EXTRASYSTOLES 3 0.0004
460 CORONARY ARTERY DISEASE 13 0.0004
461 FEELING OF DESPAIR 2 0.0004
462 BACTERIAL INFECTION 8 0.0004
463 DUODENAL ULCER 3 0.0004
464 FEAR OF INJECTION 3 0.0004
465 INCORRECT DOSE ADMINISTERED BY DEVICE 11 0.0004
466 ANGINA PECTORIS 12 0.0004
467 VISUAL FIELD DEFECT 3 0.0004
468 DEVICE LEAKAGE 18 0.0004
469 TONGUE DISORDER 3 0.0004
470 ATELECTASIS 4 0.0004
471 NOCTURIA 5 0.0004
472 HORMONE LEVEL ABNORMAL 2 0.0004
473 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
474 STEVENS-JOHNSON SYNDROME 9 0.0004
475 PLATELET COUNT DECREASED 43 0.0004
476 HAEMATOCRIT DECREASED 8 0.0004
477 ANEURYSM 2 0.0004
478 INJECTION SITE INFLAMMATION 2 0.0004
479 DEVICE USE ISSUE 7 0.0004
480 CORONARY ARTERY STENOSIS 2 0.0004
481 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
482 TROPONIN INCREASED 3 0.0004
483 AORTIC ANEURYSM 3 0.0004
484 INTERSTITIAL LUNG DISEASE 19 0.0004
485 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
486 OXYGEN SATURATION DECREASED 22 0.0004
487 PROCEDURAL COMPLICATION 3 0.0004
488 URINARY RETENTION 13 0.0004
489 PRODUCT PREPARATION ERROR 8 0.0004
490 HYPERBILIRUBINAEMIA 4 0.0004
491 TENDERNESS 4 0.0004
492 LIVER DISORDER 17 0.0004
493 ARRHYTHMIA 18 0.0004
494 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
495 FRUSTRATION TOLERANCE DECREASED 3 0.0004
496 ANAL ABSCESS 2 0.0004
497 DECUBITUS ULCER 3 0.0004
498 OESOPHAGITIS 4 0.0004
499 ESCHERICHIA INFECTION 3 0.0004
500 DEAFNESS UNILATERAL 2 0.0004
501 BLOOD PRESSURE DECREASED 24 0.0004
502 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
503 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
504 THERAPY NON-RESPONDER 16 0.0004
505 PANCREATITIS ACUTE 8 0.0004
506 DEVICE OCCLUSION 5 0.0004
507 MITRAL VALVE INCOMPETENCE 4 0.0004
508 CHOLECYSTITIS ACUTE 2 0.0004
509 DRUG EXPOSURE DURING PREGNANCY 12 0.0004
510 GENERALISED ERYTHEMA 2 0.0004
511 MICTURITION URGENCY 4 0.0003
512 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
513 PARALYSIS 5 0.0003
514 CARDIOGENIC SHOCK 5 0.0003
515 GASTRIC HAEMORRHAGE 4 0.0003
516 HAEMATOMA 9 0.0003
517 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
518 CARDIAC MURMUR 3 0.0003
519 BLOOD GLUCOSE INCREASED 65 0.0003
520 SEPTIC SHOCK 15 0.0003
521 MEDICATION ERROR 19 0.0003
522 LUNG INFILTRATION 3 0.0003
523 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
524 CARDIOMYOPATHY 5 0.0003
525 PERITONITIS 7 0.0003
526 CATARACT OPERATION 2 0.0003
527 PULMONARY HYPERTENSION 7 0.0003
528 OSTEOPENIA 5 0.0003
529 FOETAL GROWTH RESTRICTION 2 0.0003
530 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
531 EPILEPSY 10 0.0003
532 PNEUMONIA BACTERIAL 3 0.0003
533 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
534 CARDIOMEGALY 4 0.0003
535 LYMPHOMA 5 0.0003
536 EJECTION FRACTION DECREASED 5 0.0003
537 INFUSION SITE EXTRAVASATION 2 0.0003
538 SPUTUM DISCOLOURED 3 0.0003
539 MUSCLE ATROPHY 4 0.0003
540 PROTEINURIA 6 0.0003
541 PNEUMOTHORAX 5 0.0003
542 DRUG INTERACTION 50 0.0003
543 RED BLOOD CELL COUNT DECREASED 9 0.0003
544 ANAEMIA 60 0.0003
545 ULCER 5 0.0003
546 ENTERITIS 2 0.0003
547 ANOREXIA 4 0.0003
548 ANAPHYLACTIC SHOCK 8 0.0003
549 HAEMORRHOIDS 6 0.0003
550 FUNGAL INFECTION 10 0.0003
551 INJECTION SITE PAIN 92 0.0003
552 DISCOMFORT 18 0.0003
553 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
554 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
555 PERIPHERAL COLDNESS 4 0.0003
556 MUSCULOSKELETAL DISCOMFORT 5 0.0003
557 RESPIRATORY FAILURE 21 0.0003
558 NEURALGIA 7 0.0003
559 FORMICATION 2 0.0003
560 MASS 4 0.0003
561 NEUROTOXICITY 5 0.0003
562 SUDDEN DEATH 3 0.0003
563 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
564 BODY HEIGHT DECREASED 3 0.0003
565 LEUKOPENIA 14 0.0003
566 CEREBRAL HAEMORRHAGE 10 0.0003
567 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13 0.0003
568 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
569 CARDIOVASCULAR DISORDER 7 0.0003
570 LIVER FUNCTION TEST ABNORMAL 8 0.0003
571 GASTROENTERITIS 4 0.0003
572 BLOOD GLUCOSE FLUCTUATION 3 0.0003
573 CHEST DISCOMFORT 28 0.0003
574 STAPHYLOCOCCAL INFECTION 9 0.0003
575 DRUG RESISTANCE 7 0.0003
576 ACUTE MYOCARDIAL INFARCTION 8 0.0003
577 CEREBRAL DISORDER 2 0.0003
578 NERVE INJURY 3 0.0003
579 ATRIAL FIBRILLATION 26 0.0003
580 BLOOD CALCIUM DECREASED 3 0.0003
581 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
582 BLOOD SODIUM DECREASED 5 0.0003
583 BRADYCARDIA 14 0.0003
584 CHRONIC KIDNEY DISEASE 20 0.0003
585 MYOCARDITIS 3 0.0003
586 ACIDOSIS 2 0.0003
587 SEPSIS 29 0.0003
588 DEVICE RELATED INFECTION 4 0.0003
589 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
590 HAEMOLYSIS 2 0.0003
591 ELECTROLYTE IMBALANCE 3 0.0003
592 VASCULITIS 3 0.0003
593 HYPOACUSIS 11 0.0003
594 RESPIRATORY ARREST 7 0.0003
595 BLOOD PRESSURE ABNORMAL 5 0.0003
596 PYREXIA 87 0.0003
597 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
598 ATRIAL FLUTTER 2 0.0003
599 METABOLIC ACIDOSIS 8 0.0002
600 RENAL IMPAIRMENT 21 0.0002
601 HEPATIC ENZYME INCREASED 17 0.0002
602 BURSITIS 3 0.0002
603 BONE MARROW FAILURE 5 0.0002
604 LUNG DISORDER 12 0.0002
605 PHARYNGITIS 3 0.0002
606 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
607 CELLULITIS 12 0.0002
608 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
609 FACE OEDEMA 4 0.0002
610 URINARY INCONTINENCE 7 0.0002
611 RENAL INJURY 7 0.0002
612 INTRAOCULAR PRESSURE INCREASED 3 0.0002
613 MYDRIASIS 3 0.0002
614 SCAR 4 0.0002
615 HEPATIC FAILURE 7 0.0002
616 INJECTION SITE INDURATION 3 0.0002
617 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
618 DELIRIUM 8 0.0002
619 CONDITION AGGRAVATED 70 0.0002
620 PLATELET COUNT INCREASED 3 0.0002
621 HAEMORRHAGE 24 0.0002
622 BLOOD CALCIUM INCREASED 2 0.0002
623 GASTRITIS 6 0.0002
624 HEART RATE DECREASED 8 0.0002
625 GRIP STRENGTH DECREASED 2 0.0002
626 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
627 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
628 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
629 ANAL INCONTINENCE 2 0.0002
630 ABDOMINAL DISTENSION 23 0.0002
631 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
632 INCORRECT DOSE ADMINISTERED 50 0.0002
633 EXOSTOSIS 2 0.0002
634 RENAL FAILURE 29 0.0002
635 SKIN DISCOLOURATION 10 0.0002
636 RESPIRATORY DISTRESS 6 0.0002
637 URINARY TRACT INFECTION 37 0.0002
638 GRAND MAL CONVULSION 2 0.0002
639 PERICARDIAL EFFUSION 5 0.0002
640 AGRANULOCYTOSIS 4 0.0002
641 ERYTHEMA MULTIFORME 2 0.0002
642 APPENDICITIS 2 0.0002
643 RENAL FAILURE ACUTE 9 0.0002
644 MUSCULOSKELETAL PAIN 11 0.0002
645 SYNCOPE 21 0.0002
646 EYE INFLAMMATION 2 0.0002
647 PRODUCTIVE COUGH 10 0.0002
648 DIABETIC KETOACIDOSIS 5 0.0002
649 GLAUCOMA 4 0.0002
650 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
651 HYPERCHOLESTEROLAEMIA 2 0.0002
652 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
653 DYSTONIA 4 0.0002
654 PRESYNCOPE 5 0.0002
655 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
656 HEPATOMEGALY 2 0.0002
657 KNEE OPERATION 2 0.0002
658 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
659 DISORIENTATION 8 0.0002
660 BLADDER DISORDER 2 0.0002
661 MYOCARDIAL INFARCTION 35 0.0002
662 RESPIRATORY DISORDER 6 0.0002
663 HYPOTONIA 2 0.0002
664 BLOOD POTASSIUM DECREASED 6 0.0002
665 BRAIN INJURY 2 0.0002
666 CARDIAC FAILURE CONGESTIVE 16 0.0002
667 HYPOXIA 7 0.0002
668 HAEMATEMESIS 5 0.0002
669 PRODUCT USE ISSUE 37 0.0002
670 BLINDNESS 8 0.0002
671 HEPATITIS 5 0.0002
672 HYPOTENSION 39 0.0002
673 MYELOSUPPRESSION 7 0.0002
674 CARDIAC ARREST 16 0.0002
675 UNRESPONSIVE TO STIMULI 5 0.0002
676 INFECTION 28 0.0002
677 EYE DISCHARGE 2 0.0002
678 THERAPY PARTIAL RESPONDER 3 0.0002
679 RHABDOMYOLYSIS 8 0.0002
680 POLLAKIURIA 8 0.0002
681 FOLLICULITIS 2 0.0002
682 ANHEDONIA 5 0.0002
683 DEVICE ISSUE 17 0.0002
684 HALLUCINATION, VISUAL 4 0.0002
685 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
686 RASH ERYTHEMATOUS 9 0.0002
687 LOSS OF CONSCIOUSNESS 24 0.0002
688 NIGHT SWEATS 6 0.0002
689 FEAR 5 0.0002
690 VISUAL IMPAIRMENT 23 0.0002
691 DECREASED ACTIVITY 2 0.0002
692 DEEP VEIN THROMBOSIS 12 0.0002
693 HYPERTENSION 39 0.0002
694 OFF LABEL USE 161 0.0002
695 CEREBROVASCULAR ACCIDENT 31 0.0002
696 PRODUCT STORAGE ERROR 16 0.0002
697 PHOTOSENSITIVITY REACTION 3 0.0002
698 APPLICATION SITE PAIN 4 0.0002
699 STOMATITIS 11 0.0002
700 TRANSAMINASES INCREASED 4 0.0002
701 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
702 GASTROINTESTINAL DISORDER 16 0.0002
703 FISTULA 2 0.0002
704 TARDIVE DYSKINESIA 5 0.0002
705 CONTUSION 17 0.0002
706 CHOLECYSTECTOMY 2 0.0002
707 CONVULSION 10 0.0002
708 ORTHOSTATIC HYPOTENSION 3 0.0002
709 EYELID OEDEMA 2 0.0002
710 RENAL DISORDER 8 0.0002
711 INTENTIONAL PRODUCT MISUSE 15 0.0002
712 BURNING SENSATION 12 0.0002
713 HYPERKALAEMIA 6 0.0002
714 LABORATORY TEST ABNORMAL 5 0.0002
715 BACTERAEMIA 2 0.0002
716 PULMONARY EMBOLISM 16 0.0002
717 GALLBLADDER DISORDER 3 0.0002
718 ACCIDENT 2 0.0002
719 CARDIO-RESPIRATORY ARREST 7 0.0002
720 HYPOGLYCAEMIA 8 0.0002
721 NEOPLASM MALIGNANT 11 0.0002
722 BONE DISORDER 3 0.0002
723 CYTOPENIA 2 0.0002
724 HAEMATOCHEZIA 9 0.0002
725 ENCEPHALOPATHY 4 0.0002
726 INJECTION SITE MASS 6 0.0002
727 INJECTION SITE EXTRAVASATION 2 0.0002
728 CHILLS 19 0.0002
729 ABASIA 4 0.0002
730 HEART RATE INCREASED 16 0.0002
731 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
732 CYST 2 0.0002
733 MENTAL DISORDER 7 0.0002
734 PNEUMONIA 52 0.0002
735 BLISTER 9 0.0002
736 PNEUMONIA ASPIRATION 4 0.0002
737 HYPONATRAEMIA 9 0.0002
738 INTESTINAL OBSTRUCTION 6 0.0002
739 BRAIN OEDEMA 2 0.0002
740 PRODUCT COMPLAINT 4 0.0002
741 GASTRIC ULCER 3 0.0002
742 INJECTION SITE IRRITATION 2 0.0002
743 HERPES ZOSTER 9 0.0002
744 PULMONARY FIBROSIS 3 0.0002
745 SEIZURE 18 0.0002
746 HIATUS HERNIA 2 0.0002
747 EXPOSURE VIA SKIN CONTACT 4 0.0002
748 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
749 AMNESIA 10 0.0002
750 PALPITATIONS 18 0.0002
751 KIDNEY INFECTION 3 0.0002
752 BLADDER CANCER 9 0.0002
753 TINNITUS 7 0.0002
754 THROMBOCYTOPENIA 17 0.0002
755 DEPRESSED MOOD 8 0.0002
756 CATARACT 9 0.0002
757 UNDERDOSE 11 0.0002
758 UPPER LIMB FRACTURE 3 0.0002
759 BLOOD PRESSURE INCREASED 23 0.0002
760 PRESCRIBED UNDERDOSE 3 0.0002
761 THROMBOSIS 12 0.0001
762 PRODUCT PHYSICAL ISSUE 3 0.0001
763 TYPE 2 DIABETES MELLITUS 5 0.0001
764 THERAPEUTIC RESPONSE DECREASED 9 0.0001
765 OEDEMA 8 0.0001
766 LIMB INJURY 4 0.0001
767 NEUTROPHIL COUNT DECREASED 6 0.0001
768 DRUG TOXICITY 2 0.0001
769 IMPAIRED GASTRIC EMPTYING 2 0.0001
770 MOOD ALTERED 4 0.0001
771 CORONARY ARTERY OCCLUSION 2 0.0001
772 BLOOD GLUCOSE DECREASED 7 0.0001
773 PANCYTOPENIA 8 0.0001
774 WOUND 4 0.0001
775 CARPAL TUNNEL SYNDROME 2 0.0001
776 MOUTH ULCERATION 3 0.0001
777 BLINDNESS UNILATERAL 2 0.0001
778 HYPOAESTHESIA 21 0.0001
779 BRONCHOSPASM 2 0.0001
780 OEDEMA PERIPHERAL 17 0.0001
781 SKIN CANCER 3 0.0001
782 PRODUCT PRESCRIBING ISSUE 3 0.0001
783 ACCIDENTAL OVERDOSE 5 0.0001
784 RESTLESSNESS 5 0.0001
785 DEPRESSION 31 0.0001
786 OVERDOSE 29 0.0001
787 ORAL PAIN 3 0.0001
788 RASH PAPULAR 3 0.0001
789 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
790 PAIN 82 0.0001
791 HYPOAESTHESIA ORAL 2 0.0001
792 ECONOMIC PROBLEM 2 0.0001
793 COLITIS 5 0.0001
794 FEELING HOT 8 0.0001
795 CHEST PAIN 24 0.0001
796 GYNAECOMASTIA 4 0.0001
797 INJURY 9 0.0001
798 FLUSHING 13 0.0001
799 BONE DENSITY DECREASED 4 0.0001
800 COMA 6 0.0001
801 PAIN IN EXTREMITY 37 0.0001
802 BLOOD PRESSURE FLUCTUATION 3 0.0001
803 HYPERSENSITIVITY 23 0.0001
804 TACHYCARDIA 11 0.0001
805 MUSCULAR WEAKNESS 14 0.0001
806 IMPAIRED HEALING 4 0.0001
807 EYE DISORDER 4 0.0001
808 DRUG LEVEL INCREASED 2 0.0001
809 VISUAL ACUITY REDUCED 4 0.0001
810 LIP SWELLING 4 0.0001
811 SKIN DISORDER 4 0.0001
812 HOT FLUSH 9 0.0001
813 DIARRHOEA 77 0.0001
814 ANGER 4 0.0001
815 HEMIPARESIS 2 0.0001
816 CONFUSIONAL STATE 19 0.0001
817 SWELLING 11 0.0001
818 INFLAMMATION 6 0.0001
819 RASH GENERALISED 3 0.0001
820 DEVICE USE ERROR 4 0.0001
821 VERTIGO 7 0.0001
822 JOINT STIFFNESS 3 0.0001
823 EOSINOPHILIA 2 0.0001
824 SLEEP DISORDER 8 0.0001
825 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
826 DRUG ERUPTION 2 0.0001
827 BACK PAIN 26 0.0001
828 JAUNDICE 3 0.0001
829 PNEUMONITIS 3 0.0001
830 TREATMENT NONCOMPLIANCE 6 0.0001
831 FEELING COLD 3 0.0001
832 EPISTAXIS 8 0.0001
833 HEPATIC CIRRHOSIS 2 0.0001
834 DYSPNOEA EXERTIONAL 4 0.0001
835 DEVICE DIFFICULT TO USE 7 0.0001
836 HYPOCALCAEMIA 2 0.0001
837 FRACTURE 2 0.0001
838 FOOT FRACTURE 2 0.0001
839 ANXIETY 30 0.0001
840 MULTIPLE SCLEROSIS 5 0.0001
841 ACUTE KIDNEY INJURY 16 0.0001
842 ACUTE RESPIRATORY FAILURE 2 0.0001
843 MUSCLE SPASMS 19 0.0001
844 ERUCTATION 2 0.0001
845 NEUTROPENIA 14 0.0001
846 ERYTHEMA 21 0.0001
847 WHEEZING 6 0.0001
848 CONSTIPATION 22 0.0001
849 INJECTION SITE BRUISING 8 0.0001
850 CYTOKINE RELEASE SYNDROME 2 0.0001
851 APHASIA 3 0.0001
852 LUNG NEOPLASM MALIGNANT 4 0.0001
853 OSTEOPOROSIS 4 0.0001
854 FEMUR FRACTURE 3 0.0001
855 TREMOR 16 0.0001
856 CARDIAC DISORDER 9 0.0001
857 NERVOUSNESS 5 0.0001
858 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
859 HEAD INJURY 3 0.0001
860 MEMORY IMPAIRMENT 13 0.0001
861 MOVEMENT DISORDER 3 0.0001
862 LIVER FUNCTION TEST INCREASED 2 0.0001
863 HYPERHIDROSIS 12 0.0001
864 LACTIC ACIDOSIS 3 0.0001
865 UNEVALUABLE EVENT 7 0.0001
866 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
867 FAECES DISCOLOURED 2 0.0001
868 DIZZINESS 46 0.0001
869 VOMITING 43 0.0001
870 OSTEONECROSIS 3 0.0001
871 EMOTIONAL DISTRESS 11 0.0001
872 VIRAL INFECTION 3 0.0001
873 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
874 GLOSSODYNIA 2 0.0001
875 ARTHRITIS 7 0.0001
876 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
877 CHROMATURIA 2 0.0001
878 SUICIDAL IDEATION 8 0.0001
879 COUGH 24 0.0001
880 SURGERY 5 0.0001
881 NASAL CONGESTION 5 0.0001
882 LYMPHADENOPATHY 3 0.0001
883 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
884 DISEASE PROGRESSION 10 0.0001
885 NEUROPATHY PERIPHERAL 8 0.0001
886 DISEASE RECURRENCE 4 0.0001
887 IRRITABILITY 5 0.0001
888 PARAESTHESIA 13 0.0001
889 HYPERGLYCAEMIA 3 0.0001
890 LIVER INJURY 2 0.0001
891 HEADACHE 51 0.0001
892 DRUG DEPENDENCE 13 0.0001
893 EXPOSURE DURING PREGNANCY 5 0.0001
894 AGEUSIA 2 0.0001
895 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
896 ABDOMINAL PAIN LOWER 2 0.0001
897 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
898 RHINORRHOEA 5 0.0001
899 SWELLING FACE 5 0.0001
900 MYALGIA 13 0.0001
901 DYSPNOEA 43 0.0001
902 ABNORMAL BEHAVIOUR 3 0.0001
903 INFUSION RELATED REACTION 5 0.0001
904 ABORTION SPONTANEOUS 3 0.0001
905 ASTHENIA 28 0.0001
906 DISTURBANCE IN ATTENTION 4 0.0001
907 DYSKINESIA 3 0.0001
908 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
909 RASH PRURITIC 4 0.0001
910 ABNORMAL DREAMS 2 0.0001
911 DIVERTICULITIS 2 0.0001
912 FALL 24 0.0001
913 NECK PAIN 4 0.0001
914 INSOMNIA 19 0.0001
915 RECTAL HAEMORRHAGE 3 0.0001
916 DYSSTASIA 2 0.0001
917 ANGIOEDEMA 3 0.0001
918 BRONCHITIS 5 0.0001
919 THROAT IRRITATION 3 0.0001
920 ADVERSE DRUG REACTION 6 0.0001
921 NO ADVERSE EVENT 12 0.0001
922 MALAISE 29 0.0001
923 PERIPHERAL SWELLING 10 0.0001
924 EMOTIONAL DISORDER 2 0.0001
925 OROPHARYNGEAL PAIN 6 0.0001
926 INJECTION SITE ERYTHEMA 8 0.0001
927 DRUG DOSE OMISSION BY DEVICE 5 0.0001
928 GAIT DISTURBANCE 12 0.0001
929 PRURITUS 24 0.0001
930 RASH 27 0.0001
931 DYSPEPSIA 6 0.0001
932 TREATMENT FAILURE 5 0.0001
933 FEBRILE NEUTROPENIA 4 0.0001
934 DRY EYE 3 0.0001
935 AGGRESSION 3 0.0001
936 ABDOMINAL PAIN UPPER 12 0.0001
937 GASTRIC DISORDER 2 0.0001
938 VISION BLURRED 8 0.0001
939 WEIGHT INCREASED 13 0.0001
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
941 SPEECH DISORDER 3 0.0001
942 PANCREATITIS 3 0.0001
943 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
944 NAUSEA 44 0.0001
945 DEPENDENCE 3 0.0001
946 FEELING ABNORMAL 13 0.0001
947 DYSGEUSIA 4 0.0001
948 INFLUENZA 6 0.0001
949 WEIGHT DECREASED 15 0.0001
950 FLATULENCE 3 0.0001
951 INJECTION SITE SWELLING 4 0.0001
952 ABDOMINAL PAIN 12 0.0001
953 COVID-19 9 0.0001
954 BONE PAIN 3 0.0001
955 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
956 SUICIDE ATTEMPT 3 0.0000
957 SINUSITIS 5 0.0000
958 ARTHRALGIA 20 0.0000
959 URTICARIA 8 0.0000
960 DECREASED APPETITE 11 0.0000
961 DEHYDRATION 6 0.0000
962 COLITIS ULCERATIVE 2 0.0000
963 SOMNOLENCE 9 0.0000
964 DEATH 38 0.0000
965 NASOPHARYNGITIS 8 0.0000
966 MIGRAINE 4 0.0000
967 MOBILITY DECREASED 3 0.0000
968 ABDOMINAL DISCOMFORT 7 0.0000
969 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
970 DRUG INTOLERANCE 4 0.0000
971 AGITATION 3 0.0000
972 FATIGUE 31 0.0000
973 FLUID RETENTION 2 0.0000
974 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
975 ILLNESS 4 0.0000
976 ECZEMA 2 0.0000
977 DRUG ABUSE 3 0.0000
978 ARTHROPATHY 2 0.0000
979 EYE PAIN 2 0.0000
980 EYE IRRITATION 2 0.0000
981 ILL-DEFINED DISORDER 2 0.0000
982 BALANCE DISORDER 2 0.0000
983 DYSPHAGIA 2 0.0000
984 PRODUCT DOSE OMISSION ISSUE 6 0.0000
985 DRUG DOSE OMISSION 3 0.0000
986 TOXICITY TO VARIOUS AGENTS 3 0.0000
987 ASTHMA 2 0.0000
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
989 JOINT SWELLING 2 0.0000
990 ALOPECIA 3 0.0000
991 HOSPITALISATION 2 0.0000